ALFA FinderBSE filing, NSE: METROPOLIS. Summary written from the filing by ALFA Finder's alert engine.
Metropolis Healthcare Ltd: key numbers
- Share price
- ₹568.75
- Market cap
- ₹11,803 Cr
- Revenue (annual)
- ₹1,646 Cr
- Net profit (annual)
- ₹190.0 Cr
- P/E (TTM)
- 52.6×Sector 53.9×
- Promoter holding
- 47.82%-1.04% QoQ
- FII holding
- 11.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Metropolis Healthcare Ltd
All →Metropolis Healthcare Earnings Call Transcript: Key Takeaways
Metropolis delivered a robust 16% revenue growth, beating prior 12-13% organic guidance. Operating leverage is kicking in, with H1 margins expanding 190 bps despite heavy monsoon headwinds and no price hikes.
- Call
- Guides 16% growth
Metropolis Healthcare Dividend
Metropolis Healthcare declared an interim dividend of ₹1 per equity share for FY 26-27. The record date is 9 November 2026.
Metropolis Healthcare Results Update
Metropolis Healthcare posted Q2 FY27 revenue up 16% to ₹497 crore and PAT up 43% to ₹75 crore. Board declared a ₹1 per share interim dividend.
Metropolis Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 497 Cr (+16% YoY), EBITDA INR 135 Cr at 27.2% margin, PAT INR 75 Cr (+43%). H1 revenue INR 947 Cr (+16%). Strategy is Metropolis 3.0, focused on tech, science and profitable growth.
Metropolis Healthcare Q2 FY27 Results: Net Profit ₹75.5 Cr, Up 42.7% YoY
Metropolis Healthcare Ltd reported revenue from operations of ₹496.8 Cr (+15.8% YoY) and net profit of ₹75.5 Cr (+42.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹75.5 Cr · +42.7% YoY
Metropolis Healthcare Employee Stock Options
Metropolis Healthcare granted 24,060 RSUs and 3,58,920 ESOPs under its 2025 plans, and allotted 65,600 shares under its RSU Plan 2020.
Other promoter selling announcements
All →JK Cement Promoter Selling: ₹0.53 Cr
Promoter group member Kalpana Singhania sold 1,000 JK Cement shares on the NSE on 05-11-2026. Holding fell to 324,296 shares, roughly 0.41%, worth about Rs.0.53 Crore.
- Value
- ₹0.53 Cr
Alivus Life Sciences Promoter Selling
Nirma Limited, a promoter of Alivus Life Sciences, sold 36,80,000 shares (2.99%) in the open market on 6 November 2026. Promoter holding falls from 74.73% to 71.74%.
KPIT Technologies Promoter Selling: ₹0.41 Cr
KPIT Technologies promoter Hemlata Shende sold 8,000 equity shares in an open-market sale on November 4, 2026, reducing her holding to nil. The transaction value is about Rs.0.41 Crore.
- Value
- ₹0.41 Cr
JK Cement Promoter Selling
Promoter Kalpana Singhania sold 1,000 JK Cement shares via open market on 05 November 2026. Holding fell to 324,296 shares, with the stake effectively unchanged at 0.41%.
Jhaveri Credits & Capital Promoter Selling: ₹0 Cr
Promoter group member Bhumit Patel sold 90 shares via BSE market sale for Rs.15,600. Holding fell to 42,076 shares, 0.37 percent.
- Value
- ₹0.00 Cr
Sri Lotus Developers and Realty Promoter Selling: ₹573 Cr
Promoter Anand Kamalnayan Pandit sold 2.39 crore shares via NSE market sale, worth Rs.572.96 Crore. Promoter holding falls from 70.03% to 65.14%.
- Value
- ₹573.0 Cr